Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corine Bernaud

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|October 5, 2023
Clinical pharmacology of selatogrel for self-administration by patients with suspected acute myocardial infarctionMartine Gehin, Robert F Storey, Corine Bernaud, et al.
Fundamental & Clinical Pharmacology|August 18, 2004
Differential time effect profiles of amlodipine, as compared to valsartan, revealed by ambulatory blood pressure monitoring, self blood pressure measurements and dose omission protocolAnca Radauceanu, Jean-Marc Boivin, Corine Bernaud, et al.
Biomolecules|September 28, 2023
Mind the Gap: Model-Based Switching from Selatogrel to Maintenance Therapy with Oral P2Y12 Receptor AntagonistsChih-Hsuan Hsin, Jasper Dingemanse, Andrea Henrich, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 19, 2003
Amlodipine reduces cyclosporin-induced hyperuricaemia in hypertensive renal transplant recipientsJacques Chanard, Olivier Toupance, Sylvie Lavaud, et al.
American Heart Journal|December 15, 2012
EPICOR (long-tErm follow-up of antithrombotic management Patterns In acute CORonary syndrome patients) study: rationale, design, and baseline characteristicsHéctor Bueno, Nicolas Danchin, Mónica Tafalla, et al.
Fundamental & Clinical Pharmacology|April 11, 2003
Randomized, comparative, double-blind study of amlodipine vs. nicardipine as a treatment of isolated systolic hypertension in the elderlyClaire Mounier-Véhier, Olivier Jaboureck, Jean-Paul Emeriau, et al.
Fundamental & Clinical Pharmacology|August 12, 2010
Surrogate endpoints in randomized cardiovascular clinical trialsMichael Domanski, Stuart Pocock, Corine Bernaud, et al.
Journal of Cardiovascular Pharmacology|September 3, 2021
Selatogrel and Other P2Y12 Inhibitors' Putative Off-Target EffectsMarco Valgimigli, Robert F Storey, Peter R Sinnaeve, et al.
Fundamental & Clinical Pharmacology|January 30, 2004
Rationale, design and methods of the CASHMERE studyTabassome Simon, Pierre Boutouyrie, Anne Gompel, et al.
Journal of the American College of Cardiology|May 23, 2020
Subcutaneous Selatogrel Inhibits Platelet Aggregation in Patients With Acute Myocardial InfarctionPeter Sinnaeve, Gregor Fahrni, Dan Schelfaut, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Expert Opinion on Drug Metabolism & Toxicology|October 5, 2023
Clinical pharmacology of selatogrel for self-administration by patients with suspected acute myocardial infarctionMartine Gehin, Robert F Storey, Corine Bernaud, et al.
Fundamental & Clinical Pharmacology|August 18, 2004
Differential time effect profiles of amlodipine, as compared to valsartan, revealed by ambulatory blood pressure monitoring, self blood pressure measurements and dose omission protocolAnca Radauceanu, Jean-Marc Boivin, Corine Bernaud, et al.
Biomolecules|September 28, 2023
Mind the Gap: Model-Based Switching from Selatogrel to Maintenance Therapy with Oral P2Y12 Receptor AntagonistsChih-Hsuan Hsin, Jasper Dingemanse, Andrea Henrich, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 19, 2003
Amlodipine reduces cyclosporin-induced hyperuricaemia in hypertensive renal transplant recipientsJacques Chanard, Olivier Toupance, Sylvie Lavaud, et al.
American Heart Journal|December 15, 2012
EPICOR (long-tErm follow-up of antithrombotic management Patterns In acute CORonary syndrome patients) study: rationale, design, and baseline characteristicsHéctor Bueno, Nicolas Danchin, Mónica Tafalla, et al.
Fundamental & Clinical Pharmacology|April 11, 2003
Randomized, comparative, double-blind study of amlodipine vs. nicardipine as a treatment of isolated systolic hypertension in the elderlyClaire Mounier-Véhier, Olivier Jaboureck, Jean-Paul Emeriau, et al.
Fundamental & Clinical Pharmacology|August 12, 2010
Surrogate endpoints in randomized cardiovascular clinical trialsMichael Domanski, Stuart Pocock, Corine Bernaud, et al.
Journal of Cardiovascular Pharmacology|September 3, 2021
Selatogrel and Other P2Y12 Inhibitors' Putative Off-Target EffectsMarco Valgimigli, Robert F Storey, Peter R Sinnaeve, et al.
Fundamental & Clinical Pharmacology|January 30, 2004
Rationale, design and methods of the CASHMERE studyTabassome Simon, Pierre Boutouyrie, Anne Gompel, et al.
Journal of the American College of Cardiology|May 23, 2020
Subcutaneous Selatogrel Inhibits Platelet Aggregation in Patients With Acute Myocardial InfarctionPeter Sinnaeve, Gregor Fahrni, Dan Schelfaut, et al.
Pageof 2